160 related articles for article (PubMed ID: 27981434)
1. Novel Pathophysiological Mechanisms in Hypertension.
Samson R; Lee A; Lawless S; Hsu R; Sander G
Adv Exp Med Biol; 2017; 956():21-35. PubMed ID: 27981434
[TBL] [Abstract][Full Text] [Related]
2. Targeting the immune system to treat hypertension: where are we?
Gooch JL; Sharma AC
Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):473-9. PubMed ID: 25036747
[TBL] [Abstract][Full Text] [Related]
3. The role of Immunity in Fabry Disease and Hypertension: A Review of a Novel Common Pathway.
Del Pinto R; Ferri C
High Blood Press Cardiovasc Prev; 2020 Dec; 27(6):539-546. PubMed ID: 33047250
[TBL] [Abstract][Full Text] [Related]
4. Inflammation in the pathophysiology of essential hypertension.
Montecucco F; Pende A; Quercioli A; Mach F
J Nephrol; 2011; 24(1):23-34. PubMed ID: 20437401
[TBL] [Abstract][Full Text] [Related]
5. The renin-angiotensin-aldosterone system: focus on its distinct role in arterial hypertension and its various inhibitors as a therapeutic strategy to effectively lower blood pressure.
Soldner A; Spahn-Langguth H; Mutschler E
Pharmazie; 1996 Nov; 51(11):783-99. PubMed ID: 8985974
[TBL] [Abstract][Full Text] [Related]
6. Clinical role of direct renin inhibition in hypertension.
Taylor AA; Pool JL
Am J Ther; 2012 May; 19(3):204-10. PubMed ID: 21317620
[TBL] [Abstract][Full Text] [Related]
7. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
Horký K
Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
[TBL] [Abstract][Full Text] [Related]
8. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
Abassi Z; Armaly Z; Nakhoul F; Hoffman A
Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
[TBL] [Abstract][Full Text] [Related]
9. Relevance of Immune-Sympathetic Nervous System Interplay for the Development of Hypertension.
Winklewski PJ; Radkowski M; Demkow U
Adv Exp Med Biol; 2016; 884():37-43. PubMed ID: 26453069
[TBL] [Abstract][Full Text] [Related]
10. The immune system in hypertension.
Harrison DG
Trans Am Clin Climatol Assoc; 2014; 125():130-38; discussion 138-40. PubMed ID: 25125726
[TBL] [Abstract][Full Text] [Related]
11. Recent Advances in Immunity and Hypertension.
Lopez Gelston CA; Mitchell BM
Am J Hypertens; 2017 Jul; 30(7):643-652. PubMed ID: 28200062
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-(1-7) as a strategy in the treatment of hypertension?
van Twist DJ; Kroon AA; de Leeuw PW
Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):480-6. PubMed ID: 25023950
[TBL] [Abstract][Full Text] [Related]
13. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
14. Newer renin-angiotensin-aldosterone system blocker combinations: is there an advantage?
Lazich I; Bakris GL
Curr Opin Nephrol Hypertens; 2011 Sep; 20(5):471-5. PubMed ID: 21709549
[TBL] [Abstract][Full Text] [Related]
15. The interplay between Angiotensin II, TLR4 and hypertension.
Biancardi VC; Bomfim GF; Reis WL; Al-Gassimi S; Nunes KP
Pharmacol Res; 2017 Jun; 120():88-96. PubMed ID: 28330785
[TBL] [Abstract][Full Text] [Related]
16. Statins, the renin-angiotensin-aldosterone system and hypertension - a tale of another beneficial effect of statins.
Drapala A; Sikora M; Ufnal M
J Renin Angiotensin Aldosterone Syst; 2014 Sep; 15(3):250-8. PubMed ID: 25037529
[TBL] [Abstract][Full Text] [Related]
17. Endothelial Dysfunction and Hypertension.
Konukoglu D; Uzun H
Adv Exp Med Biol; 2017; 956():511-540. PubMed ID: 28035582
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic possibilities for the inhibition of the renin-angiotensin-aldosterone system].
Abrahám G; Légrády P
Orv Hetil; 2003 May; 144(18 Suppl 1):892-5. PubMed ID: 12785232
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure.
Brooks DP; Ruffolo RR
J Hypertens Suppl; 1999 Jun; 17(2):S27-32. PubMed ID: 10465064
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory cytokines regulate renal sodium transporters: how, where, and why?
Norlander AE; Madhur MS
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F141-F144. PubMed ID: 28404590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
